Bangladesh · Delayed Price · Currency is BDT Orion Infusion Statistics
Total Valuation
Orion Infusion has a market cap or net worth of BDT 7.36 billion. The enterprise value is 7.63 billion.
| Market Cap | 7.36B |
| Enterprise Value | 7.63B |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | Dec 2, 2025 |
Share Statistics
Orion Infusion has 20.36 million shares outstanding.
| Current Share Class | 20.36M |
| Shares Outstanding | 20.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 196.55.
| PE Ratio | 196.55 |
| Forward PE | n/a |
| PS Ratio | 11.07 |
| PB Ratio | 22.75 |
| P/TBV Ratio | 22.75 |
| P/FCF Ratio | 108.73 |
| P/OCF Ratio | 107.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 79.17, with an EV/FCF ratio of 112.67.
| EV / Earnings | 203.69 |
| EV / Sales | 11.47 |
| EV / EBITDA | 79.17 |
| EV / EBIT | 92.98 |
| EV / FCF | 112.67 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.96.
| Current Ratio | 0.96 |
| Quick Ratio | 0.36 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | 4.57 |
| Interest Coverage | 2.02 |
Financial Efficiency
Return on equity (ROE) is 11.79% and return on invested capital (ROIC) is 10.63%.
| Return on Equity (ROE) | 11.79% |
| Return on Assets (ROA) | 6.05% |
| Return on Invested Capital (ROIC) | 10.63% |
| Return on Capital Employed (ROCE) | 23.32% |
| Weighted Average Cost of Capital (WACC) | -7.95% |
| Revenue Per Employee | 1.18M |
| Profits Per Employee | 66,548 |
| Employee Count | 563 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 2.84 |
Taxes
In the past 12 months, Orion Infusion has paid 9.40 million in taxes.
| Income Tax | 9.40M |
| Effective Tax Rate | 20.05% |
Stock Price Statistics
The stock price has decreased by -0.50% in the last 52 weeks. The beta is -2.36, so Orion Infusion's price volatility has been lower than the market average.
| Beta (5Y) | -2.36 |
| 52-Week Price Change | -0.50% |
| 50-Day Moving Average | 366.42 |
| 200-Day Moving Average | 400.03 |
| Relative Strength Index (RSI) | 47.66 |
| Average Volume (20 Days) | 339,688 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Orion Infusion had revenue of BDT 665.43 million and earned 37.47 million in profits. Earnings per share was 1.84.
| Revenue | 665.43M |
| Gross Profit | 277.23M |
| Operating Income | 82.08M |
| Pretax Income | 46.86M |
| Net Income | 37.47M |
| EBITDA | 89.60M |
| EBIT | 82.08M |
| Earnings Per Share (EPS) | 1.84 |
Balance Sheet
The company has 36.69 million in cash and 309.45 million in debt, with a net cash position of -267.42 million or -13.13 per share.
| Cash & Cash Equivalents | 36.69M |
| Total Debt | 309.45M |
| Net Cash | -267.42M |
| Net Cash Per Share | -13.13 |
| Equity (Book Value) | 323.73M |
| Book Value Per Share | 15.90 |
| Working Capital | -22.29M |
Cash Flow
In the last 12 months, operating cash flow was 68.46 million and capital expenditures -730,515, giving a free cash flow of 67.73 million.
| Operating Cash Flow | 68.46M |
| Capital Expenditures | -730,515 |
| Free Cash Flow | 67.73M |
| FCF Per Share | 3.33 |
Margins
Gross margin is 41.66%, with operating and profit margins of 12.33% and 5.63%.
| Gross Margin | 41.66% |
| Operating Margin | 12.33% |
| Pretax Margin | 7.04% |
| Profit Margin | 5.63% |
| EBITDA Margin | 13.46% |
| EBIT Margin | 12.33% |
| FCF Margin | 10.18% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | 66.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 62.65% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.55% |
| Earnings Yield | 0.51% |
| FCF Yield | 0.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Orion Infusion has an Altman Z-Score of 10.31 and a Piotroski F-Score of 6.
| Altman Z-Score | 10.31 |
| Piotroski F-Score | 6 |